HDAC INHIBITOREN

Patent europeic · EP2970139 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2970139
Numer da la dumonda
EP14722448
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-03-2014
Publitgà
20-01-2016
Concedì
30-05-2018
Stritgà
25-10-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 231/56 (2006.01)
C07D 401/06 (2006.01)
A61K 31/416 (2006.01)
A61P 25/00 (2006.01)
Prioritad
US 201361800170 P 15.03.2013
US 201361863235 P 07.08.2013
Dumonda PCT
PCT/US2014/027633 14.03.2014
Publicaziun PCT
WO2014/143666 18.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-10-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.10.2022

  2. 16-05-2022

    Adressa midada

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  3. 03-08-2018

    Represchentant inscrit

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 03.08.2018

  4. 30-05-2018

    Concedì

    Published in Swissreg on 30.05.2018

Partidas

Possessur

Biomarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

105 Digital Drive, Novato, CA 94949, US

Represchentant

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

Inventur

JACQUES, Vincent

Somerville, MA 02144, US

RUSCHE, James, R.

Framingham, MA 01702, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.